E-LIB Suche - Ergebnisse für: Haslett, K.

1

OC-0462 Using the right tools to do the job right; evaluati..:

Rodgers, J. ; Booth, A. ; Triffitt, C....
Radiotherapy and Oncology. 182 (2023) - p. S365-S366 , 2023

Link: https://doi.org/10.1016/..

2

PD-0824 Development of a hypoxia gene signature in locally ..:

Datta, A. ; Reardon, M. ; Desai, S....
Radiotherapy and Oncology. 182 (2023) - p. S693-S694 , 2023

Link: https://doi.org/10.1016/..

3

PO-1348 Prognostic factors in patients receiving palliative..:

Kombathula, S.H. ; Cree, A. ; Joshi, P.V....
Radiotherapy and Oncology. 170 (2022) - p. S1143-S1144 , 2022

Link: https://doi.org/10.1016/..

4

PO-1940 Variation in bladder filling for cervical cancer pa..:

Nelder, C. ; Chuter, R. ; Berresford, J....
Radiotherapy and Oncology. 161 (2021) - p. S1653-S1654 , 2021

Link: https://doi.org/10.1016/..

5

Phase I trial of the MEK inhibitor selumetinib in combinati..:

Haslett, K. ; Koh, P. ; Hudson, A....
Clinical and Translational Radiation Oncology. 28 (2021) - p. 24-31 , 2021

Link: https://doi.org/10.1016/..

6

Embodied Motherhood: Exploring Body Image in Pregnant and P..:

Harrison, M.E. ; Obeid, N. ; Haslett, K...
Journal of Pediatric and Adolescent Gynecology. 32 (2019) 1 - p. 44-50 , 2019

Link: https://doi.org/10.1016/..

7

Phase I trial evaluating MEK inhibitor selumetinib with con..:

Haslett, K. ; Blackhall, F. ; Koh, P....
Lung Cancer. 115 (2018) - p. S65 , 2018

Link: https://doi.org/10.1016/..

8

Single institution analysis of pneumocystis jirovecii pneum..:

Croxford, W. ; Haslett, K. ; Syed, J....
Lung Cancer. 115 (2018) - p. S9-S10 , 2018

Link: https://doi.org/10.1016/..

9

PO-0753: Phase I trial evaluating MEK inhibitor selumetinib..:

Haslett, K. ; Blackhall, F. ; Koh, P....
Radiotherapy and Oncology. 127 (2018) - p. S387-S388 , 2018

Link: https://doi.org/10.1016/..

10

Isotoxic intensity modulated radiotherapy (IMRT) in stage I..:

Haslett, K. ; Ashcroft, L. ; Bayman, N....
Lung Cancer. 115 (2018) - p. S62-S63 , 2018

Link: https://doi.org/10.1016/..

11

PO-0752: Isotoxic Intensity Modulated Radiotherapy in stage..:

Haslett, K. ; Ashcroft, L. ; Bayman, N....
Radiotherapy and Oncology. 127 (2018) - p. S387 , 2018

Link: https://doi.org/10.1016/..

12

Posttreatment Lymphocytopenia, Integral Heart Dose, and Ove..:

Joseph, N. ; McWilliam, A. ; Kennedy, J....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. S36 , 2017

Link: https://doi.org/10.1016/..

13

143: The management of patients with extensive-stage small-..:

Haslett, K. ; De Ruysscher, D. ; Dziadziuszko, R....
Lung Cancer. 103 (2017) - p. S64-S65 , 2017

Link: https://doi.org/10.1016/..

14

PO-0952: Integral heart dose and lymphocytopaenia in lung c..:

Joseph, N. ; McWilliam, A. ; Haslett, K....
Radiotherapy and Oncology. 123 (2017) - p. S527 , 2017

Link: https://doi.org/10.1016/..

15

136 Electronic patient reported outcomes significantly impr..:

Shears, A. ; Bayman, N. ; Harris, M....
Lung Cancer. 91 (2016) - p. S49-S50 , 2016

Link: https://doi.org/10.1016/..